🎙️ Welcome to TechPod by Biotech Social – where science meets storytelling, powered by AI.

💊 “If exercise were a pill, it would be the best-selling drug in history.”
In this episode, we dive into a brand-new review published in the Journal of Applied Physiology (June 2025; PMID: 40244910 – open access), led by Glenn A. Gaesser and colleagues.

🔬 What you’ll learn:

• Why exercise and caloric restriction are the two strongest levers to extend our healthspan (not just lifespan).

• How health can be seen as a portfolio strategy – combining movement, nutrition, and even humor (yes, Monty Python’s “Silly Walks” included).

• The science-backed ROI: more years of independence, energy, and mental clarity.

At Biotech Social, we’re passionate about translating cutting-edge science into conversations that inspire action. With TechPod, we also leverage AI assistance to distill insights, making research more accessible and engaging.

👉 Tune in, reflect, and ask yourself: What’s in your personal health portfolio right now?

In this episode of the Biology Career Insights (BCI) Podcast, we welcome Professor Robert A. Harris, Professor of Immunotherapy in Neurological Diseases at the Karolinska Institutet and Academic Vice-President for Doctoral Education.Prof. Harris has made pioneering contributions to our understanding of chronic neurological diseases such as multiple sclerosis, ALS, Alzheimer’s disease, and brain tumors. His work has advanced the fields of personalized cell therapy and immunomodulation, while his leadership has shaped doctoral education for over 2,000 PhD students at Karolinska.We dive deep into his remarkable career journey—from his early inspirations in science, through decades of impactful research, to his leadership roles at an international level. Prof. Harris also shares valuable advice for aspiring scientists, educators, and leaders in life sciences.🔹 What You’ll Learn in This Episode:Prof. Harris’s early career journey and academic rootsBreakthroughs in neuroimmunology and their real-world impactInsights into doctoral education and supervisionBalancing research, teaching, and leadership rolesAdvice for PhD students and postdocs on career development🎧 Subscribe & Follow the Biology Career Insights Podcast:🌐 Website: https://www.bcipodcast.eu📱 LinkedIn: https://www.linkedin.com/company/bcipodcastYoutube: https://www.youtube.com/watch?v=Tq2gUUtDUvE

In this episode, we dive into a groundbreaking 2025 study from Emory University that shows psilocybin, the compound found in psychedelic mushrooms, reversed signs of aging and extended lifespan in mice by 30%. Even more mind-blowing? Human skin and lung cells lived over 50% longer in lab studies.Our AI-generated hosts, explore the science behind how psilocybin impacts oxidative stress, telomere length, DNA repair — and what it all means for human longevity and the future of anti-aging therapies.🔬 What you'll learn:How psychedelics may fight aging at the cellular levelThe science behind telomeres and lifespanWhy mice on psilocybin looked and aged betterWhat this could mean for humans and longevity medicineThe link between mental health, psychedelics, and healthy aging📚 Based on the 2025 study published in npj Aging:“Psilocybin treatment extends cellular lifespan and improves survival of aged mice”Authors: Louise Hecker, Ali John Zarrabi, et al.DOI: 10.1038/s41514-025-00244-x💬 Sound off in the comments: Would you consider psychedelic therapy for longevity?👇 Don’t forget to like, subscribe, and turn on notifications for more AI-powered episodes on cutting-edge biotech, mental health, and aging.#Psilocybin #AntiAging #MagicMushrooms #Longevity #BiotechPodcast #HealthyAging #Psychedelics #AIpodcastTranscript

UCLA scientists may have just revolutionized the future of hair loss treatment. In this episode, we explore the groundbreaking discovery of PP405, a small molecule that awakens dormant hair follicle stem cells — leading to full hair regrowth.Backed by promising early human trials, this innovation goes far beyond the limited results of traditional treatments. Discover how Professors William Lowry, Heather Christofk, and Michael Jung are reshaping the field of regenerative medicine — and how their spinout company, Pelage Pharmaceuticals, is racing toward FDA approval.🎙️ Powered by AI🔬 Based on verified science💡 For anyone curious about the future of hair restoration👉 Subscribe for more science-based podcast episodes driven by AI🔗 [Insert link to sources or article, if available]#HairLoss #UCLA #StemCells #HairRegrowth #Baldness #SciencePodcast #Biotech #PP405 #PelagePharmaceuticals

PhD Might Not Be Worth It?

With more PhD graduates now working outside of academia, it's worth asking: Is a doctorate always worth it?A 2023 UK study found that while PhD holders generally earn more per hour than master’s graduates, the difference isn’t universal. In fields like law, economics, and management, master’s degree holders actually earned slightly more.Even more interesting: when factoring in years of work experience, master’s graduates across all fields edged out PhDs in earnings.💡 This challenges the assumption that more education always means more pay, especially outside academia.What do you think? Is the PhD still worth it in today’s job market? Or is a master’s degree enough?🎧 Subscribe in now to remain updated: https://lnkd.in/eE9dteWySource: https://lnkd.in/dEZQiAkg hashtag#PhD hashtag#Podcast hashtag#HigherEducation hashtag#AcademicCareers hashtag#DoctoralTraining hashtag#CareerDevelopment hashtag#Education hashtag#Postgraduate hashtag#PhD hashtag#MastersDegree hashtag#WorkplaceTrends

In this episode of Biology Career Insights, we sit down with Patrick Bongartz, Co-Founder and CEO of BioThrust, a biotech startup revolutionizing cell culture processes with its patented bubble-free, low-shear bioreactor technology.Patrick takes us through his inspiring journey—from his academic foundation at RWTH Aachen University to founding BioThrust in 2020, and how he and his co-founders tackled key challenges in bioprocessing. We talk about the technical innovation behind their ComfyCell system, the evolution of cell and gene therapy, and what it means to build a startup in today’s complex biotech landscape.This candid conversation covers:Patrick’s academic and entrepreneurial backgroundThe story and mission behind BioThrustDeep dive into bioprocessing innovation: bubble-free aerationTrends in MSC, CAR-T, and HEK scale-upInsights from ISCT and ASGCT 2025 conferencesReflections on co-founder dynamics, fundraising, and navigating uncertainty in biotechAdvice for aspiring scientists and biotech entrepreneurs✨ A huge thanks to Patrick for generously sharing his story and insights!🔔 Subscribe for more conversations with biotech leaders: https://youtube.com/@bcipodcast

📩 Learn more or get in touch: www.bcipodcast.eu

In the biotech world, flashy ads just don’t cut it. Scientists, researchers, and decision-makers aren’t persuaded by slogans—they’re influenced by evidence, insight, and authentic expertise.That’s why educational content isn’t just a nice-to-have—it’s the most effective marketing strategy in biotech today.In this video, we explore how formats like:🎙️ Podcasts✍️ Blog Posts📢 Webinars...offer far more than visibility. They:Build trust by speaking the language of data and discoveryPosition your brand as a thought leader, not just a vendorCreate lasting engagement with communities that care about why, not just what✅ It's time to sell less and teach more.If you’re still chasing clicks instead of building credibility, it’s time to rethink your biotech marketing playbook.👉 How are you using educational content to lead with value?🔔 Subscribe for more insights on content strategy, science communication, and building brand authority in the biotech space.#BiotechMarketing #ContentStrategy #STEMMarketing #ThoughtLeadership #PodcastMarketing #ScienceCommunication #B2BMarketing #EducationalContent

In this episode we discuss a breakthrough in organoid research by Stanford Medicine scientists, who successfully created heart and liver organoids with their own functional blood vessel systems. Traditionally, organoids have been limited in size due to their inability to receive oxygen and nutrients, but this new development allows for larger, more mature organoids that better mimic human organs. These vascularized organoids hold significant promise for advancing research into human development and disease, as well as paving the way for future regenerative therapies, such as implantable tissue grown from a patient's own stem cells. The research involved optimizing chemical "recipes" to reliably produce the necessary cell types for blood vessel formation, demonstrating a successful method that could be applied to other organoid types.